Revenue Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Kunming Longjin Pharmaceutical Co., Ltd.'s latest annual revenue in 2023 was 86.62 Million CNY , down -29.56% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd.'s latest quarterly revenue in 2024 Q3 was 7.11 Million CNY , down -44.84% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported a annual revenue of 122.96 Million CNY in annual revenue 2022, down -82.5% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported a annual revenue of 702.51 Million CNY in annual revenue 2021, up 176.55% from previous year.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly revenue of 13.02 Million CNY for 2024 Q2, down -49.1% from previous quarter.
Kunming Longjin Pharmaceutical Co., Ltd. reported a quarterly revenue of 25.6 Million CNY for 2024 Q1, up 64.43% from previous quarter.

Annual Revenue Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Year	Revenue	Revenue Growth
2023	86.62 Million CNY	-29.56%
2022	122.96 Million CNY	-82.5%
2021	702.51 Million CNY	176.55%
2020	254.02 Million CNY	-7.72%
2019	275.29 Million CNY	-18.06%
2018	335.98 Million CNY	10.36%
2017	304.44 Million CNY	36.14%
2016	223.63 Million CNY	23.26%
2015	181.42 Million CNY	-3.19%
2014	187.4 Million CNY	4.78%
2013	178.85 Million CNY	-1.8%
2012	182.13 Million CNY	22.6%
2011	148.55 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q3	7.11 Million CNY	-44.84%
2024 Q2	13.02 Million CNY	-49.1%
2024 Q1	25.6 Million CNY	64.43%
2023 Q2	22.08 Million CNY	2.44%
2023 FY	86.62 Million CNY	-29.56%
2023 Q4	15.56 Million CNY	-43.22%
2023 Q3	27.41 Million CNY	24.18%
2023 Q1	21.55 Million CNY	6.77%
2022 Q2	30.54 Million CNY	-35.78%
2022 Q4	20.18 Million CNY	-18.17%
2022 Q1	47.56 Million CNY	-56.24%
2022 FY	122.96 Million CNY	-82.5%
2022 Q3	24.66 Million CNY	-19.24%
2021 Q4	108.7 Million CNY	-44.61%
2021 Q1	206.12 Million CNY	129.94%
2021 Q2	191.41 Million CNY	-7.13%
2021 Q3	196.27 Million CNY	2.54%
2021 FY	702.51 Million CNY	176.55%
2020 FY	254.02 Million CNY	-7.72%
2020 Q3	63.88 Million CNY	8.03%
2020 Q2	59.13 Million CNY	42.93%
2020 Q1	41.37 Million CNY	-52.47%
2020 Q4	89.64 Million CNY	40.33%
2019 Q2	65.93 Million CNY	1.11%
2019 Q1	65.21 Million CNY	-22.6%
2019 Q4	87.04 Million CNY	52.43%
2019 FY	275.29 Million CNY	-18.06%
2019 Q3	57.1 Million CNY	-13.4%
2018 FY	335.98 Million CNY	10.36%
2018 Q4	84.25 Million CNY	0.21%
2018 Q3	84.08 Million CNY	-0.84%
2018 Q2	84.79 Million CNY	2.35%
2018 Q1	82.84 Million CNY	-7.31%
2017 Q3	82.39 Million CNY	12.51%
2017 Q4	89.38 Million CNY	8.48%
2017 Q2	73.23 Million CNY	23.24%
2017 Q1	59.42 Million CNY	-17.71%
2017 FY	304.44 Million CNY	36.14%
2016 Q4	72.22 Million CNY	26.16%
2016 Q3	57.24 Million CNY	15.5%
2016 Q2	49.56 Million CNY	11.11%
2016 Q1	44.6 Million CNY	-0.81%
2016 FY	223.63 Million CNY	23.26%
2015 Q4	44.97 Million CNY	4.07%
2015 Q2	46.57 Million CNY	-0.21%
2015 Q3	43.21 Million CNY	-7.21%
2015 FY	181.42 Million CNY	-3.19%
2015 Q1	46.67 Million CNY	-18.8%
2014 Q1	39.03 Million CNY	0.0%
2014 Q2	47.72 Million CNY	22.29%
2014 Q3	43.16 Million CNY	-9.57%
2014 Q4	57.47 Million CNY	33.16%
2014 FY	187.4 Million CNY	4.78%
2013 FY	178.85 Million CNY	-1.8%
2012 FY	182.13 Million CNY	22.6%
2011 FY	148.55 Million CNY	0.0%

Peer Revenue Comparison of Kunming Longjin Pharmaceutical Co., Ltd.

Name	Revenue	Revenue Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	36.41 Billion CNY	99.762%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.27 Billion CNY	97.974%
Dong-E-E-Jiao Co.,Ltd.	4.71 Billion CNY	98.163%
Livzon Pharmaceutical Group Inc.	12.27 Billion CNY	99.295%
Hainan Haiyao Co., Ltd.	1.45 Billion CNY	94.056%
Tus-Pharmaceutical Group Co., Ltd.	395.92 Million CNY	78.121%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.44 Billion CNY	97.489%
Changchun High-Tech Industries (Group) Inc.	14.46 Billion CNY	99.401%
Apeloa Pharmaceutical Co.,Ltd	11.47 Billion CNY	99.245%
PKU HealthCare Corp.,Ltd.	2.19 Billion CNY	96.051%
Chengdu Huasun Technology Group Inc., Ltd.	1 Billion CNY	91.367%
Dezhan Healthcare Company Limited	498.08 Million CNY	82.609%
Jinling Pharmaceutical Company Limited	2.78 Billion CNY	96.891%
Jiuzhitang Co., Ltd.	2.91 Billion CNY	97.033%
Huapont Life Sciences Co., Ltd.	11.59 Billion CNY	99.253%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	3.95 Billion CNY	97.808%
Shandong Wohua Pharmaceutical Co., Ltd.	894.31 Million CNY	90.314%
Hengkang Medical Group Co., Ltd.	3.59 Billion CNY	97.587%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2.61 Billion CNY	96.682%
Qianjiang Yongan Pharmaceutical Co., Ltd.	962.8 Million CNY	91.003%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.42 Billion CNY	98.402%
Jinhe Biotechnology CO., LTD.	2.17 Billion CNY	96.016%
Teyi Pharmaceutical Group Co.,Ltd	1.06 Billion CNY	91.883%
Beijing Aosaikang Pharmaceutical Co., Ltd.	1.44 Billion CNY	93.999%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	3.95 Billion CNY	97.811%
Anhui Huangshan Capsule Co., Ltd.	458.36 Million CNY	81.102%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	980.82 Million CNY	91.168%
Zhuhai Rundu Pharmaceutical Co., Ltd.	1.29 Billion CNY	93.295%
Huaren Pharmaceutical Co., Ltd.	1.63 Billion CNY	94.706%
Tianjin Ringpu Bio-Technology Co.,Ltd.	2.24 Billion CNY	96.148%
Shanxi Zhendong Pharmaceutical Co.,Ltd	3.62 Billion CNY	97.611%
Fuan Pharmaceutical (Group) Co., Ltd.	2.64 Billion CNY	96.728%
Hybio Pharmaceutical Co., Ltd.	431.38 Million CNY	79.92%
Baotou Dongbao Bio-Tech Co.,Ltd	974.51 Million CNY	91.111%
Hunan Er-Kang Pharmaceutical Co., Ltd	1.76 Billion CNY	95.104%
Changjiang Pharmaceutical Group Co., Ltd.	1.19 Billion CNY	92.767%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.09 Billion CNY	92.087%
Fujian Cosunter Pharmaceutical Co., Ltd.	422.71 Million CNY	79.508%
Beijing Science Sun Pharmaceutical Co., Ltd.	476.56 Million CNY	81.824%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	270.39 Million CNY	67.965%
Hainan Poly Pharm. Co., Ltd	1.3 Billion CNY	93.36%
Jiangxi Synergy Pharmaceutical Co., Ltd.	722.13 Million CNY	88.005%
Wuhan Hiteck Biological Pharma Co.,Ltd	602.28 Million CNY	85.618%
Shandong Xinhua Pharmaceutical Company Limited	8 Billion CNY	98.918%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	2.52 Billion CNY	96.572%
PharmaBlock Sciences (Nanjing), Inc.	1.72 Billion CNY	94.979%
Jinghua Pharmaceutical Group Co., Ltd.	1.49 Billion CNY	94.188%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	2.17 Billion CNY	96.012%
Betta Pharmaceuticals Co., Ltd.	2.45 Billion CNY	96.473%
Tibet AIM Pharm. Inc.	667.03 Million CNY	87.014%
Shenzhen Kangtai Biological Products Co., Ltd.	3.47 Billion CNY	97.509%
Shandong Shanda Wit Science and Technology Co., Ltd.	2.48 Billion CNY	96.513%
Pacific Shuanglin Bio-pharmacy Co., LTD	2.32 Billion CNY	96.28%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	1.62 Billion CNY	94.672%
Xiamen Kingdomway Group Company	3.1 Billion CNY	97.208%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	799.3 Million CNY	89.163%
Walvax Biotechnology Co., Ltd.	4.11 Billion CNY	97.894%
Sunflower Pharmaceutical Group Co.,Ltd	5.63 Billion CNY	98.462%
Harbin Gloria Pharmaceuticals Co., Ltd	2.58 Billion CNY	96.655%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	24.73 Billion CNY	99.65%
Hunan Hansen Pharmaceutical Co., Ltd.	955.53 Million CNY	90.935%
Changzhou Qianhong Biopharma CO.,LTD	1.79 Billion CNY	95.171%
Shenzhen Weiguang Biological Products Co., Ltd.	1.04 Billion CNY	91.738%
Honz Pharmaceutical Co., Ltd.	739.56 Million CNY	88.287%
Northeast Pharmaceutical Group Co., Ltd.	8.16 Billion CNY	98.939%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.46 Billion CNY	94.078%
Guizhou Xinbang Pharmaceutical Co., Ltd.	6.46 Billion CNY	98.659%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	1.13 Billion CNY	92.335%
Zhejiang Yatai Pharmaceutical Co., Ltd.	420.64 Million CNY	79.407%
Zhejiang NHU Company Ltd.	15.11 Billion CNY	99.427%
ApicHope Pharmaceutical Co., Ltd	2.5 Billion CNY	96.54%
Shanghai Kaibao Pharmaceutical CO.,Ltd	1.59 Billion CNY	94.566%
Beijing SL Pharmaceutical Co., Ltd.	1.01 Billion CNY	91.494%
Yunnan Baiyao Group Co.,Ltd	38.9 Billion CNY	99.777%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.08 Billion CNY	91.98%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	839.25 Million CNY	89.679%
Guangdong Lifestrong Pharmacy Co., Ltd.	292.39 Million CNY	70.375%
Huadong Medicine Co., Ltd	40.39 Billion CNY	99.786%
Jiangsu Nhwa Pharmaceutical Co., LTD	4.97 Billion CNY	98.258%
Harbin Medisan Pharmaceutical Co., Ltd.	1.18 Billion CNY	92.701%
LanZhou Foci Pharmaceutical Co.,Ltd.	1.16 Billion CNY	92.553%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	6.12 Billion CNY	98.586%
Beijing Beilu Pharmaceutical Co., Ltd	890.71 Million CNY	90.275%
Nanjing Hicin Pharmaceutical Co., Ltd.	517.83 Million CNY	83.272%
Renhe Pharmacy Co., Ltd.	5.03 Billion CNY	98.279%
Chongqing Pharscin Pharmaceutical Co., Ltd.	691.54 Million CNY	87.474%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	4.12 Billion CNY	97.899%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	2.34 Billion CNY	96.302%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	4.26 Billion CNY	97.968%

Global Stocks Search

Kunming Longjin Pharmaceutical Co., Ltd. (002750.SZ)

Revenue Summary of Kunming Longjin Pharmaceutical Co., Ltd.

Annual Revenue Chart of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Historical Annual Revenue of Kunming Longjin Pharmaceutical Co., Ltd. (2023 - 2011)

Peer Revenue Comparison of Kunming Longjin Pharmaceutical Co., Ltd.